The present invention relates to a prosthesis for the repair of hernias, and in particular a prosthesis adapted for the repair of inguinal hernias by laparoscopy.
In a general manner, prostheses for the repair of the inguinal region and for the treatment of hernias comprise an openworked prosthetic textile which is made of biocompatible synthetic material and may or may not be absorbable, depending on whether the prosthesis is intended to remain permanently in the body of the patient or, by contrast, is intended to disappear once cell recolonization has taken place.
When repair of a hernia in the inguinal region is performed by a posterior and extraperitoneal laparoscopic route, it is important to be able to locate, and to cover with the prosthesis, certain anatomical elements of the anterior wall of the abdomen, which elements may be described as follows, from the inside outwards, and for the right-hand side of the body with reference to
The peritoneum is not shown in
It will be noted in
When operating using a posterior and extra-peritoneal route, whether by open surgery or by laparoscopy, the surgeon has to bring the prosthesis into this inguinal region and then place it correctly with respect to all the elements described above.
Furthermore, in order to shorten the duration of an intervention and thereby minimize the number of steps to be performed during an operation, it is possible to use prostheses made from an arrangement of yarns, a knit, a woven or non-woven fabric, comprising barbs protruding outwards from one face of the prosthesis: these barbs constitute structures such as hooks that are able to fix themselves directly in the biological tissues, for example the elements of the inguinal region that have been described above. With such prostheses, it is possible to dispense with steps involving fixing by sutures or staples.
The laparoscopic route requires only very small incisions for the passage of a trocar, through which the prosthesis is delivered to the implantation site. Open surgery is thus avoided, and the patient is soon able to leave hospital. The laparoscopic route is particularly prized in surgical interventions performed in the region of the abdomen, for example in the treatment of hernias.
However, the trocars used in the laparoscopic approach generally have a relatively small calibrated diameter, which can vary from 5 to 15 mm for example, in order to reduce as much as possible the size of the incision that is made. The prosthesis therefore has to be delivered through a conduit of small diameter, and it then has to be deployed at the implantation site.
To perform this step, the prosthesis is generally rolled up on itself, so as to slide it into the conduit of the trocar, or introduced directly with force. However, when the prosthetic textile forming the prosthesis comprises barbs on one face, it can happen that these barbs catch in the body of the textile, thus making subsequent deployment of the prosthesis at the implantation site more difficult. Moreover, because of the obliqueness of the inguinal region and the restricted deployment space, it can prove complicated to deploy the prosthesis and then orient it suitably with respect to the orifice of the inguinal canal.
Therefore, there is still a need for a prosthesis for repair of inguinal hernias that is capable of being delivered through a conduit, such as that of a trocar, to the inguinal region and that is then capable of deploying completely, and preferably easily, and of being oriented and positioned easily once the implantation site in the patient's body has been reached.
The present invention aims to meet such a need.
A first aspect of the invention is a prosthesis for repair of an inguinal hernia, which prosthesis is intended to be implanted by a posterior or open laparoscopic route and comprises:
an openworked textile made of biocompatible material, comprising a first face intended to be placed facing the biological tissues of the inguinal region, and a second face arranged opposite said first face and intended to be placed facing the peritoneum,
said first face being provided with fastening means that are able to fix said textile in said biological tissues of the inguinal region,
characterized in that at least a part of said second face is covered with a non-porous coating consisting in a material that is hydrosoluble at 37° C. and non-hydrosoluble at a temperature of less than or equal to 25° C.
The present application also relates to a method for producing a prosthesis of the above type, characterized in that it comprises the following steps:
an openworked textile of biocompatible material is made available comprising a first face, provided with fastening means that are able to fix said textile in biological tissues of the inguinal region, and a second face,
at least a part of said second face is covered with a non-porous coating consisting in a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C.
In the present application, “biological tissues of the inguinal region” are understood as the biological tissues of the organs or elements of the inguinal region that are shown in
According to the present application, “textile” is understood as any arrangement or assembly of biocompatible yarns, fibres, filaments and/or multifilaments, for example obtained by knitting, weaving, braiding, or non-woven. The arrangement of yarns of the textile according to the invention defines at least two opposite faces, namely a first face and a second face.
In the present application, “openworked textile” is understood as any textile in which the arrangement of yarns from which it is made defines openings, cells or holes within the thickness of the textile and on the faces of the textile, these openings, cells or holes being able to form channels opening out on each side of the textile. Such an openworked textile permits better tissue integration.
The textile according to the invention additionally comprises fastening means that are able to fix said textile in said biological tissues of the inguinal region. For example, these fastening means are barbs protruding from said first face. These fastening means or barbs can protrude from said first face in a manner substantially perpendicular to the plane of said face or, alternatively, in one or more planes inclined with respect to the plane of said face. These barbs are intended to function as fixing means by anchoring themselves in the biological tissues of the inguinal region.
The textile of the prosthesis according to the invention is covered at least partially on its second face, that is to say on its face opposite the face comprising the barbs, with a non-porous coating composed of a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C.
In the present application, “hydrosoluble” is understood as the ability of a material to dissolve in an aqueous composition such as water or in the biological fluids at a given temperature. The hydrosoluble material of the coating of the prosthesis according to the invention has the ability to be hydrosoluble at 37° C. and thus able to dissolve in the biological fluids of a human body, but to be non-hydrosoluble at a temperature of less than or equal to 25° C. and therefore unable to dissolve in an aqueous composition between 20° C. and 25° C.
The time it takes to dissolve at 37° C., for example in the human body, is short, for example varying from 15 minutes to about 4 weeks.
The prosthesis according to the invention can be delivered easily to the implantation site, namely the inguinal region, by means of a trocar and can then be easily deployed at the implantation site. Indeed, the particular nature of the non-porous coating of the second face of the textile of the prosthesis according to the invention makes it possible both to hydrate the prosthesis before its introduction into the trocar and also to fold it optimally in order to facilitate its passage through the trocar and also its subsequent deployment. Indeed, the non-hydrosoluble nature of the non-porous coating at 25° C. makes it possible to hydrate the prosthesis at ambient temperature, that is to say at a temperature ranging from 20 to 25° C., without compromising the integrity of said coating. It has been found that, with prior hydration of this kind, the textile, and therefore the prosthesis, could be made more pliable and therefore easier to manipulate so as to fold it optimally for easy passage through the trocar and for optimized deployment on leaving the trocar. Thus, once it has been hydrated, it is possible for the prosthesis according to the invention to be folded such that most of the fastening means find themselves in contact with said non-porous coating, which has not yet dissolved. Thus, the fastening means of the first face of the textile do not in practice catch in the openings of the second face of the same textile, even when the prosthesis is pushed through the trocar, in which it is subject to the stress exerted by the inner walls of the trocar.
Thus, when the prosthesis leaves the trocar and arrives in the inguinal region, the fastening means are not entangled in the textile, and the prosthesis according to the invention can be easily deployed. At the implantation site in the human body, where the temperature is about 37.5° C., the non-porous coating dissolves upon contact with the aqueous biological fluids. Therefore, this avoids an excessive amount of foreign material being introduced long-term into the patient.
In one embodiment of the invention, said non-porous coating is present over the whole of the second face of said textile. It thus suffices to roll up the textile of the prosthesis according to the invention on itself, for example with the fastening means to the outside, in order to form a roll of the prosthesis that can be introduced into and then pushed through a trocar. Since the fastening means are thus in contact with the non-porous coating, they do not become entangled in the openings of the textile, and the deployment of the prosthesis when it leaves the trocar is easy.
In one embodiment of the prosthesis according to the invention, with said textile having the overall shape of a rectangle with length L and width l, said textile determines in the direction of its width l a first part called the upper part, intended to be placed facing the anterior muscle wall, the upper part of the os pubis and Cooper's ligament, and a second part called the lower part, intended to be placed facing the iliac and spermatic vessels and part of the psoas muscle, said non-porous coating being present on the second face of the textile over at least an upper region of said upper part.
Thus, as will be explained later in the detailed description, it is possible to fold the textile of the prosthesis of the invention in such a way that the fastening means do not become entangled in the textile during the passage of the prosthesis through the trocar, and in such a way that the deployment of the prosthesis is easy when it leaves the trocar. In one embodiment of the invention, said porous coating is present only on said upper region of said upper part. By virtue of the specific folding of the prosthesis as explained below, such an embodiment not only allows the prosthesis to be delivered to the implantation site by trocar without the fastening means inconveniently catching and with easy deployment of said prosthesis, but also limits the amount of foreign material, such as the material of the non-porous coating, that is introduced into the patient's body and that has to be eliminated by the patient's metabolism. Therefore, said upper region, that is to say the surface of the second face of the textile covered by the non-porous coating, preferably represents approximately two thirds of the surface of said upper part. Such embodiments make it possible to fold the prosthesis to permit passage of the prosthesis through the trocar without the fastening means catching in the textile, while at the same time minimizing the amount of foreign material, such as the non-porous coating, introduced into the human body during implantation of the prosthesis.
In one embodiment of the prosthesis according to the invention, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol. An aspect of the invention is therefore a prosthesis for repair of an inguinal hernia, which prosthesis is intended to be implanted by a posterior or open laparoscopic route and comprises:
an openworked textile made of biocompatible material, comprising a first face intended to be placed facing the biological tissues of the inguinal region, and a second face arranged opposite said first face and intended to be placed facing the peritoneum,
said first face being provided with fastening means that are able to fix said textile in said biological tissues of the inguinal region,
characterized in that at least a part of said second face is covered with a non-porous coating consisting in a mixture of pepsin-treated collagen and glycerol. The collagen can be oxidized or non-oxidized. Such a mixture makes it possible to obtain a non-porous coating that does not dissolve upon contact with an aqueous composition at a temperature of 20-25° C. but that does dissolve in the human body at 37° C., within a period of between 15 minutes and 4 weeks, and that is then eliminated naturally by the human metabolism.
The non-oxidized pepsin-treated collagen suitable for preparing the non-porous coating according to the invention can be prepared, for example, as follows: pigskins are ground in acid medium in order to obtain a paste, after which the dermis is precipitated in the presence of NaCl solution. The dermis is then degreased in the presence of solvents, then digested in the presence of hydrochloric acid and pepsin. After extraction of the pepsin, the product obtained is treated with sodium hydroxide (precipitation and viral deactivation) and then treated using hydrochloric acid, followed by drying in the presence of solvents.
In order to obtain a non-porous coating that takes longer to dissolve, it is possible to use oxidized pepsin-treated collagen. For example, the non-oxidized pepsin-treated collagen obtained above can be oxidized by treatment with periodic acid in the presence of hydrochloric acid. These chemical agents permit oxidation of hydroxylysine and therefore chemical cross-linking of the collagen on itself by subsequent increase in the pH of the solution of oxidized collagen.
The non-porous coating can, for example, be in the form of a film obtained by jellification of a solution containing a mixture of oxidized or non-oxidized pepsin-treated collagen and glycerol.
In one embodiment, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol and is in the form of a film, the surface density of pepsin-treated collagen ranging from 2 to 8 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2. The respective surface densities of the pepsin-treated collagen and of the glycerol in the film are calculated from the initial concentrations of these components in the solution prior to jellification.
In one embodiment, said non-porous coating consists in a mixture of non-oxidized pepsin-treated collagen and glycerol and is in the form of a film, the surface density of non-oxidized pepsin-treated collagen ranging from 2.6 to 8 mg/cm2, and preferably being approximately 5 mg/cm2, for example approximately 5.29 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2, and preferably being approximately 3 mg/cm2, for example approximately 2.35 mg/cm2. Such embodiments allow the non-porous coating to rapidly dissolve upon contact with the biological fluids at 37° C., for example within a period of between 15 minutes and 48 hours. Moreover, it has been found that a textile in which at least a part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating.
In another embodiment of the prosthesis according to the invention, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of oxidized pepsin-treated collagen ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2. Like above, the respective surface densities of the oxidized pepsin-treated collagen and of the optional other components in the film are calculated from the initial concentrations of these components in the solution prior to jellification. Such an embodiment allows less rapid dissolution of the non-porous coating upon contact with the biological fluids at 37° C., for example within a period of 1 to 4 weeks. Moreover, it has been found that a textile in which at least a part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating. A non-porous coating of this kind also allows adherences to be minimized.
In other embodiments of the prosthesis according to the invention, the non-porous coating comprises polyvinyl alcohol, optionally glycerol and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises polyvinyl alcohol, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of polyvinyl alcohol ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, and the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2.
In one embodiment of the prosthesis according to the invention, the prosthesis is provided with a means for indicating the orientation of the prosthesis.
As has been seen above, the specific nature of the inguinal region, which is not symmetrical, means that the orientation of the prosthesis is imperative during implantation. This is because the upper part of the prosthesis often has a larger surface than the lower part. It is therefore imperative that the upper part of the prosthesis is correctly positioned facing the anterior muscle wall, the upper part of the os pubis and Cooper's ligament, and that the lower part of the prosthesis is correctly positioned facing the iliac and spermatic vessels and part of the psoas muscle. For example, said means for indicating the orientation of the prosthesis is in the form of a zone having a different colour than the rest of the prosthesis. In one embodiment of the invention, with said textile being in the form of a knit, the zone of different colour is obtained by knitting with a yarn of a different colour than the yarn or yarns used for knitting the rest of said textile. Such an embodiment therefore requires only a single knitting step in order to produce both the textile forming the prosthesis and also the means for indicating the orientation of this prosthesis. The method of production of the prosthesis is thus optimized. Moreover, since said means for indicating the orientation of the prosthesis is therefore integral with said textile, there is no risk of its detaching from the prosthesis. In particular, there is no risk of its being damaged during passage of the prosthesis through the trocar for delivering the prosthesis to the implantation site.
In one embodiment of the invention, said means for indicating the orientation of the prosthesis is situated in a medial part of the prosthesis. Within the context of the present application, “medial part” is understood as the part situated in the direction of the median plane of the human body. Thus, in the case where the means for indicating the orientation of the prosthesis according to the invention is, for example, a band with a colour different than the rest of the prosthesis, and this band is situated in the medial part of the prosthesis, the surgeon immediately knows that he has to direct this band of colour towards the os pubis when positioning the prosthesis. The surgical manoeuvre is thus made easier for him.
In one embodiment of the invention, said textile comprises a seam that at least partially delimits a border between said upper part and said lower part, said seam generally following an oblique line that starts from a starting point situated in the lower portion of a side of width l of said rectangle and terminates at an end point situated approximately at two thirds of the length L of the rectangle and half way along the width l of the rectangle. Thus, the seam can also serve as a positioning guide for the surgeon, this seam preferably having to be placed in the inguinal region at the intersection of the parietal and vascular planes to permit optimal positioning of the prosthesis. In one embodiment of the invention, said seam forms a fold of the textile, said fold causing said lower part of said textile to form naturally an angle to the plane of said upper part of said textile. Thus, the seam can give the textile a three-dimensional shape, similar to the anatomy of the inguinal region, by forming a fold in the textile, in such a way that the lower part of the textile tends naturally to form an angle with the upper part of said textile, this angle corresponding to the angle formed anatomically by the intersection of the parietal and vascular planes.
In one embodiment of the prosthesis according to the invention, said textile is a knit based on at least a first yarn of biocompatible polymer material defining said first and second faces, and at least a second yarn in the form of a biocompatible hot-melt monofilament forming said fastening means by melting of loops generated by said second yarn, the pattern chart followed for knitting said first and second yarns on a warp knitting machine with three guide bars B1, B2, B3 being the following, according to the standard ISO 11676:
said second yarn following the pattern chart of bar B3.
Such an embodiment makes it possible to optimize the formation of the openings of the textile in order to further limit the possibilities of entanglement of the fastening means in the textile.
In one embodiment of the invention, said first yarn is a monofilament yarn of polyethylene terephthalate (PET) and said second yarn is a monofilament yarn of polylactic acid (PLA). Such an embodiment makes it possible to obtain a textile that further limits the possibilities of entanglement of the fastening means in the textile, since the different monofilament yarns are less likely than multifilament yarns to catch the fastening means.
The present application also describes a method for treatment of an inguinal hernia, comprising the following steps:
During the hydration of the prosthesis, before its introduction into the trocar, the non-porous coating maintains its integrity: it does not dissolve in the saline composition since the temperature does not exceed 25° C. Thus, the prosthesis can be easily folded to permit optimal passage through the trocar. Once the prosthesis has been delivered to the implantation site, with the biological fluids of the patient's body being at a temperature of close to 37° C., the non-porous coating dissolves.
By virtue of the fastening means, such as barbs, the prosthesis of the invention fixes naturally to the biological tissues of the inguinal region.
The advantages of the present invention will become clearer from the following detailed description and example and from the attached drawings, in which:
Referring to
The textile 2 can be any arrangement or assembly of biocompatible yarns, fibres, filaments and/or multifilaments, obtained by knitting, weaving, braiding, or non-woven, said arrangement defining openings, cells or holes within the thickness of the textile and on the faces of the textile, these openings, cells or holes being able to form channels opening out on each side of the textile 2. Such an openworked textile 2 permits better tissue integration.
The yarns or fibres or filaments and/or multifilaments forming the arrangement of yarns constituting the textile 2 of the prosthesis according to the invention can be made of any biodegradable or non-biodegradable biocompatible material. Thus, the biodegradable materials suitable for the yarns of the textile 2 of the prosthesis 1 according to the present invention can be chosen from polylactic acid (PLA), polyglycolic acid (PGA), oxidized cellulose, polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHAs), copolymers of these compounds and mixtures thereof. The non-biodegradable materials suitable for the yarns of the textile 2 of the prosthesis 1 according to the present invention can be chosen from polyethylene terephthalate (PET), polyamides, aramids, expanded polytetrafluoroethylene, polyurethane, polyvinylidene difluoride (PVDF), polybutyl esters, polyetheretherketone (PEEK), polyolefins (such as polyethylene or polypropylene), polyethers, copper alloys, silver alloys, platinum, medical grades of steel such as medical-grade stainless steel, and combinations thereof.
Referring to
The fastening means, for example the barbs 3, of the textile 2 of the prosthesis according to the invention can be formed from yarns, for example hot-melt monofilament yarns issuing directly from the arrangement of yarns forming the textile. Textiles and barbs of this kind, and the method of producing them, are described, for example, in the applications WO01/81667 and DE 198 32 634 or in the U.S. Pat. Nos. 6,596,002 and 5,254,133.
For example, the barbs 3 are formed from monofilament yarns made of polylactic acid.
Alternatively, the fastening means, for example the barbs, of the textile of the prosthesis according to the invention can be any kind of hook made entirely from biocompatible material and integral with the arrangement of yarns forming said textile, irrespective of whether these hooks have been incorporated in said fabric during the manufacture (braiding, knitting, weaving, etc.) of said arrangement of yarns or have been attached later.
Preferably, as is shown in
Textiles with barbs suitable for the present invention are described in WO01/81667, for example, or are also commercially available from the company Sofradim Production under the trade name Parietex® Progrip or Parietene® Progrip.
In one embodiment, the textile 2 is a knit based on at least a first yarn of biocompatible polymer material defining said first and second faces (2a, 2b) and at least a second biocompatible hot-melt monofilament yarn forming said fastening means by melting of loops generated by said second yarn, the pattern chart followed for knitting said first and second yarns on a warp knitting machine with three guide bars B1, B2, B3 being the following, according to the standard ISO 11676:
said second yarn following the pattern chart of bar B3.
The above pattern chart is illustrated in
Moreover, and also preferably, said first yarn is a monofilament yarn of polyethylene terephthalate (PET) and said second yarn is a monofilament yarn of polylactic acid (PLA).
The first yarn(s) of the knit according to the invention are those that follow the pattern charts for bars B1 and B2. They constitute the foundation or base of the knit of the prosthesis 1 according to the invention, since the second yarn, namely a hot-melt monofilament yarn, which generates the barbs 3, is regularly cut in the area of the loops that it forms. The generation of barbs from loops of hot-melt yarn is known and is described, for example, in the document WO01/81667. When the first yarn(s) are monofilament yarns, the possible presence of asperities or of points of fastening of the barbs is limited, and the force needed to unroll the knit after the prosthesis has been rolled up as described above is very low.
The textile 2 of the prosthesis according to the invention can have a thickness, including the length of the barbs 3, of from 1 to 2 mm, for example approximately 1.4 mm.
Referring to
For example, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol.
In one embodiment, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol and is in the form of a film, the surface density of pepsin-treated collagen ranging from 2 to 8 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2.
For example, said non-porous coating consists in a mixture of non-oxidized pepsin-treated collagen and glycerol and is in the form of a film, the surface density of non-oxidized pepsin-treated collagen ranging from 2.6 to 8 mg/cm2, and preferably being about 5.29 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2, and preferably being approximately 2.35 mg/cm2. Such an embodiment allows the non-porous coating to rapidly dissolve on contact with the biological fluids at 37° C., for example between 15 minutes and 48 hours. Moreover, it has been found that a textile in which at least part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating.
In another embodiment of the prosthesis according to the invention, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol, and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of oxidized pepsin-treated collagen ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2. Such an embodiment allows less rapid dissolution of the non-porous coating on contact with the biological fluids at 37° C., for example from 1 to 4 weeks. Moreover, it has been found that a textile in which at least part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating. A non-porous coating of this kind also allows adherences to be minimized.
In other embodiments of the prosthesis according to the invention, the non-porous coating comprises polyvinyl alcohol, optionally glycerol, and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises polyvinyl alcohol, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of polyvinyl alcohol ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, and the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2.
Referring to
As will be seen from these figures and from
In another embodiment of the prosthesis according to the invention, shown in
Referring to
Referring to
Thus, by virtue of the presence of the seam 4, as will be seen from
Preferably, the upper part 6 can have a height of up to approximately 15 cm, and the lower part 5 can have a depth of between approximately 2 cm and approximately 6 cm.
A prosthesis of this kind ensures that all of the anatomical elements described above are covered, without leaving empty spaces that could possibly cause a recurrence. In particular, the region around the iliac and spermatic vessels is particularly well protected. This therefore avoids one of the main causes of secondary hernias, which can be even more difficult to treat on account of the deterioration of the anatomical structures that has been caused by the earlier hernia.
The prosthesis according to the invention, in particular the prosthesis 1 of
The use and the implantation of the prosthesis according to the invention will now be described with reference to the treatment of an inguinal hernia on the right-hand side of a patient by a posterior laparoscopic approach using the prosthesis 1 from
The technique used in the laparoscopic intervention, for example, is well known to a person skilled in the art and, consequently, will not be described in detail. In this technique, one or more trocars are introduced into the extraperitoneal space, that is to say posterior to the rectus abdominis muscle and the fascia transversalis, the extraperitoneal working space being created by insufflation and separation of the peritoneum and the abdominal wall.
The perspective views in
It can be clearly seen in
To proceed with the intervention, the surgeon takes hold of the prosthesis 1 from
The folding of the prosthesis 1 from
Referring to
As will be clear from the description of this folding, the presence of the non-porous coating 7 on only approximately two thirds of the surface of the upper part 6 of the textile 2 corresponds to an advantageous embodiment of the prosthesis 1 according to the invention. This is because this embodiment not only makes it possible to deliver the prosthesis 1 to the implantation site by trocar, without entanglement of the barbs 3 and with easy deployment of said prosthesis 1 as will be described hereinbelow, but also makes it possible to limit the amount of material constituting a foreign body, such as the material of the non-porous coating 7, that is introduced into the patient's body and that has to be eliminated by the patient's metabolism.
The surgeon then introduces the folded prosthesis 1 into the trocar in order to deliver the prosthesis to the implantation site in the inguinal region. Despite the stress exerted by the walls of the trocar, the barbs 3 do not become entangled in the openings of the textile 2 by virtue of the presence of the non-porous coating 7 which forms a barrier and does not dissolve.
Once it is at the implantation site, namely in the inguinal region as described with reference to
By virtue of the band 9 that has a colour different than the colour of the rest of the prosthesis 1, and that is situated in the medial part of the prosthesis 1, the surgeon easily orients this medial part in the direction of the os pubis 17 (
The surgeon fits the prosthesis 1 in place facing the surrounding biological tissues, by positioning the upper part 6 of the textile 2 facing the anterior muscle wall, the upper part of the os pubis 17 and Cooper's ligament 21, and the lower part 5 of the textile facing the iliac and spermatic vessels 11 and part of the psoas muscle, if appropriate with the aid of the seam 4, for example by placing the latter at the intersection of the parietal and vascular planes, the first face 2a provided with the barbs 3 being placed against the biological tissues of the inguinal region, and the second face 2b, of which the non-porous coating 7 dissolves on contact with the biological fluids at 37° C., being placed against the peritoneum (not shown).
By virtue of the barbs 3, the prosthesis 1 fixes naturally to the biological tissues of the inguinal region, and an additional step of fixing with staples or sutures is not necessary.
When the prosthesis 1 is implanted (reference may usefully be made to
The prosthesis 1 according to the invention remains in place by itself, particularly on account of its three-dimensional shape, since the seam 4 takes up a position at the intersection of the parietal and vascular planes. This allows the prosthesis 1 to follow the changes in the relative position of the various anatomical elements of the inguinal region, which changes result from the normal movement of the abdominal muscles of the subject, but without its moving away from the implantation region.
A prosthesis according to the invention is produced as follows:
1) Preparation of a Textile in the Form of a Knit in which the Means for Indicating the Orientation of the Prosthesis is Incorporated During Knitting
On a warp knitting machine with three guide bars B1, B2, B3, a knit was produced having the following pattern chart according to the standard ISO 11676:
These pattern charts are illustrated in
Bar B1 and bar B2 are each threaded 1 full, 1 empty, with a monofilament yarn of polyethylene terephthalate (PET) of diameter 0.09 mm; bar B3 is threaded 1 full, 3 empty, with a thermoplastic monofilament yarn of polylactic acid of diameter 0.15 mm.
The pattern chart for bar B3 causes the thermoplastic monofilament yarn of polylactic acid to form loops. These loops are then melted, as is described in WO01/81667, in order to form barbs protruding from the first face of the textile, each loop giving rise to two barbs. The barbs that are obtained generally have the shape of a stalk topped by a head, as is shown in
The knit obtained has a thickness, including the length of the barbs, of approximately 1.4 mm.
The pattern chart followed for knitting the yarns of the knit of the present example generates a particular structure of the textile, that is to say a specific arrangement between the different openings in the faces of the textile, the respective size of these different openings and the disposition and distribution of the barbs being such that, even if some of the barbs present on the first face are trapped within some of the openings present on the second face when the prosthesis is rolled up on itself under the effect of an external stress, for example the stresses exerted by the surgeon when folding the prosthesis in order to introduce it into a trocar, then the stress exerted by the inner walls of the trocar, a large number of the trapped barbs will be freed automatically or under the effect of a very weak unrolling force when said stress is relaxed. This effect is reinforced by the fact that the yarns used are monofilament yarns.
In order that the means for indicating the orientation of the prosthesis is incorporated during the above knitting phase, bars B1 and B2 are threaded over a certain distance with PET monofilament yarns of a first colour, for example white, then over a defined second distance with PET monofilament yarns of another colour, for example green, and this is repeated over the entire width of the knitting machine.
This results, for example, in a succession of white bands and green bands. For example, the white bands 31 have a width Ib of 31 cm, and the green bands 32 have a width Iv of 9 cm, as is shown in
Again with reference to
2) Preparation of the Composition Intended to Form the Coating of Non-Porous Material
Particles of non-oxidized pepsin-treated collagen are prepared by grinding pigskins in acid medium in order to obtain a paste, after which the dermis is precipitated in the presence of NaCl solution. The dermis is then degreased in the presence of solvents, then digested in the presence of hydrochloric acid and pepsin. After extraction of the pepsin, the product obtained is treated with sodium hydroxide (precipitation and viral deactivation) and then treated using hydrochloric acid, followed by drying in the presence of solvents.
The particles of pepsin-treated collagen are then mixed with stirring at 40° C. in a solution of glycerol in water: the pH of the composition obtained is adjusted to 7.0 using a solution of sodium hydroxide (NaOH).
The composition is then heated at 60° C. with stirring, then filtered. The temperature is then brought back to 40° C., and the pH is adjusted between 4.5 and 7.0 with either a base (NaOH) or an acid (HCl), if necessary.
The concentration of the composition is adjusted to 5.4% (w/w) for the collagen and to 2.4% (w/w) for the glycerol.
The composition is maintained at 40° C.
3) Application of the Composition Obtained Under 2) to a Textile Obtained Under 1), in the Form of a Film
The composition obtained under 2) is deposited on the second face 2b of the textile (2; 102):
The composition is applied with a density of 0.092 ml/cm2. It forms a gel in approximately 45 minutes.
The assembly “textile+gelled composition” is then dried in air for 12 hours until a film is obtained.
In the film, the surface density of pepsin-treated collagen is approximately 5 mg/cm2, and the surface density of glycerol is approximately 3 mg/cm2.
This film is non-hydrosoluble at a temperature of 20 to 25° C. and is hydrosoluble at a temperature of approximately 37° C. It dissolves in the biological fluids in approximately 15 minutes.
Prostheses according to the invention are thus obtained, for example a prosthesis 101 according to
Number | Date | Country | Kind |
---|---|---|---|
11/62531 | Dec 2011 | FR | national |
This application is a divisional of U.S. Patent Application Ser. No. 14/366,332 filed Jun. 18, 2014, now U.S. Pat. No. 10,080,639, which is a National Stage Application of PCT/EP2012/076983 under 35USC § 371 (a), which claims priority of French Patent Application Serial No. 11/62531 filed Dec. 29, 2011, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
1187158 | Mcginley | Jun 1916 | A |
3054406 | Usher | Sep 1962 | A |
3118294 | Van Laethem | Jan 1964 | A |
3122479 | Smith | Feb 1964 | A |
3124136 | Usher | Mar 1964 | A |
3272204 | Artandi et al. | Sep 1966 | A |
3276448 | Kronenthal | Oct 1966 | A |
3320649 | Naimer | May 1967 | A |
3364200 | Ashton et al. | Jan 1968 | A |
3570482 | Shigeru et al. | Mar 1971 | A |
3718725 | Hamano | Feb 1973 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4060081 | Yannas et al. | Nov 1977 | A |
4173131 | Melton et al. | Nov 1979 | A |
4193137 | Heck | Mar 1980 | A |
4248064 | Odham | Feb 1981 | A |
4294241 | Miyata | Oct 1981 | A |
4307717 | Hymes et al. | Dec 1981 | A |
4338800 | Matsuda | Jul 1982 | A |
4476697 | Schafer et al. | Oct 1984 | A |
4487865 | Balazs et al. | Dec 1984 | A |
4500676 | Balazs et al. | Feb 1985 | A |
4511653 | Play et al. | Apr 1985 | A |
4527404 | Nakagaki et al. | Jul 1985 | A |
4563184 | Korol | Jan 1986 | A |
4591501 | Cioca | May 1986 | A |
4597762 | Walter et al. | Jul 1986 | A |
4603695 | Ikada et al. | Aug 1986 | A |
4631932 | Sommers | Dec 1986 | A |
4670014 | Huc et al. | Jun 1987 | A |
4709562 | Matsuda | Dec 1987 | A |
4728642 | Pawelchak et al. | Mar 1988 | A |
4748078 | Doi et al. | May 1988 | A |
4759354 | Quarfoot | Jul 1988 | A |
4769038 | Bendavid et al. | Sep 1988 | A |
4796603 | Dahlke et al. | Jan 1989 | A |
4813942 | Alvarez | Mar 1989 | A |
4841962 | Berg et al. | Jun 1989 | A |
4854316 | Davis | Aug 1989 | A |
4925294 | Geshwind et al. | May 1990 | A |
4931546 | Tardy et al. | Jun 1990 | A |
4942875 | Hlavacek et al. | Jul 1990 | A |
4948540 | Nigam | Aug 1990 | A |
4950483 | Ksander et al. | Aug 1990 | A |
4970298 | Silver et al. | Nov 1990 | A |
4976737 | Leake | Dec 1990 | A |
5002551 | Linsky et al. | Mar 1991 | A |
5015584 | Brysk | May 1991 | A |
5116357 | Eberbach | May 1992 | A |
5147374 | Fernandez | Sep 1992 | A |
5162430 | Rhee et al. | Nov 1992 | A |
5171273 | Silver et al. | Dec 1992 | A |
5176692 | Wilk et al. | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5195542 | Gazielly et al. | Mar 1993 | A |
5196185 | Silver et al. | Mar 1993 | A |
5201745 | Tayot et al. | Apr 1993 | A |
5201764 | Kelman et al. | Apr 1993 | A |
5206028 | Li | Apr 1993 | A |
5217493 | Raad et al. | Jun 1993 | A |
5254133 | Seid | Oct 1993 | A |
5256418 | Kemp et al. | Oct 1993 | A |
5258000 | Gianturco | Nov 1993 | A |
5263983 | Yoshizato et al. | Nov 1993 | A |
5304595 | Rhee et al. | Apr 1994 | A |
5306500 | Rhee et al. | Apr 1994 | A |
5324775 | Rhee et al. | Jun 1994 | A |
5328955 | Rhee et al. | Jul 1994 | A |
5334527 | Brysk | Aug 1994 | A |
5339657 | Mcmurray | Aug 1994 | A |
5350583 | Yoshizato et al. | Sep 1994 | A |
5356432 | Rutkow et al. | Oct 1994 | A |
5368549 | Mcvicker | Nov 1994 | A |
5368602 | Torre | Nov 1994 | A |
5370650 | Jonathan et al. | Dec 1994 | A |
5376375 | Rhee et al. | Dec 1994 | A |
5376376 | Li | Dec 1994 | A |
5397331 | Himpens et al. | Mar 1995 | A |
5399361 | Song et al. | Mar 1995 | A |
5413791 | Rhee et al. | May 1995 | A |
5425740 | Hutchinson, Jr. | Jun 1995 | A |
5428022 | Palefsky et al. | Jun 1995 | A |
5433996 | Kranzler et al. | Jul 1995 | A |
5441491 | Verschoor et al. | Aug 1995 | A |
5441508 | Gazielly et al. | Aug 1995 | A |
5456693 | Conston et al. | Oct 1995 | A |
5456711 | Hudson | Oct 1995 | A |
5466462 | Rosenthal et al. | Nov 1995 | A |
5480644 | Freed | Jan 1996 | A |
5487895 | Dapper et al. | Jan 1996 | A |
5490984 | Freed | Feb 1996 | A |
5512291 | Li | Apr 1996 | A |
5512301 | Song et al. | Apr 1996 | A |
5514181 | Light et al. | May 1996 | A |
5522840 | Krajicek | Jun 1996 | A |
5523348 | Rhee et al. | Jun 1996 | A |
5536656 | Kemp et al. | Jul 1996 | A |
5543441 | Rhee et al. | Aug 1996 | A |
5565210 | Rosenthal et al. | Oct 1996 | A |
5567806 | Abdul-Malak et al. | Oct 1996 | A |
5569273 | Titone et al. | Oct 1996 | A |
RE35399 | Eisenberg | Dec 1996 | E |
5593441 | Lichtenstein et al. | Jan 1997 | A |
5595621 | Light et al. | Jan 1997 | A |
5601571 | Moss | Feb 1997 | A |
5607474 | Athanasiou et al. | Mar 1997 | A |
5607590 | Shimizu | Mar 1997 | A |
5614587 | Rhee et al. | Mar 1997 | A |
5618551 | Tardy et al. | Apr 1997 | A |
5634931 | Kugel | Jun 1997 | A |
5639796 | Lee | Jun 1997 | A |
5665391 | Lea | Sep 1997 | A |
5667839 | Berg | Sep 1997 | A |
5676967 | Williams et al. | Oct 1997 | A |
5681568 | Goldin et al. | Oct 1997 | A |
5686090 | Schilder et al. | Nov 1997 | A |
5686115 | Vournakis et al. | Nov 1997 | A |
5690675 | Sawyer et al. | Nov 1997 | A |
5695525 | Mulhauser et al. | Dec 1997 | A |
5697978 | Sgro | Dec 1997 | A |
5700476 | Rosenthal et al. | Dec 1997 | A |
5700477 | Rosenthal et al. | Dec 1997 | A |
5702416 | Kieturakis et al. | Dec 1997 | A |
5709934 | Bell et al. | Jan 1998 | A |
5711960 | Shikinami | Jan 1998 | A |
5716409 | Debbas | Feb 1998 | A |
5720981 | Eisinger | Feb 1998 | A |
5732572 | Litton | Mar 1998 | A |
5743917 | Saxon | Apr 1998 | A |
5749895 | Sawyer et al. | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5766246 | Mulhauser et al. | Jun 1998 | A |
5766631 | Arnold | Jun 1998 | A |
5769864 | Kugel | Jun 1998 | A |
5771716 | Schlussel | Jun 1998 | A |
5785983 | Furlan et al. | Jul 1998 | A |
5800541 | Rhee et al. | Sep 1998 | A |
5814328 | Gunasekaran | Sep 1998 | A |
5833705 | Ken et al. | Nov 1998 | A |
5840011 | Landgrebe et al. | Nov 1998 | A |
5861034 | Taira et al. | Jan 1999 | A |
5863984 | Doillon et al. | Jan 1999 | A |
5869080 | Mcgregor et al. | Feb 1999 | A |
5871767 | Dionne et al. | Feb 1999 | A |
5876444 | Lai | Mar 1999 | A |
5891558 | Bell et al. | Apr 1999 | A |
5899909 | Claren et al. | May 1999 | A |
5906937 | Sugiyama et al. | May 1999 | A |
5910149 | Kuzmak | Jun 1999 | A |
5911731 | Pham et al. | Jun 1999 | A |
5916225 | Kugel | Jun 1999 | A |
5919232 | Chaffringeon et al. | Jul 1999 | A |
5919233 | Knopf et al. | Jul 1999 | A |
5922026 | Chin | Jul 1999 | A |
5931165 | Reich et al. | Aug 1999 | A |
5942278 | Hagedorn et al. | Aug 1999 | A |
5962136 | Dewez et al. | Oct 1999 | A |
5972022 | Huxel | Oct 1999 | A |
RE36370 | Li | Nov 1999 | E |
5993844 | Abraham et al. | Nov 1999 | A |
5994325 | Roufa et al. | Nov 1999 | A |
5997895 | Narotam et al. | Dec 1999 | A |
6001895 | Harvey et al. | Dec 1999 | A |
6008292 | Lee et al. | Dec 1999 | A |
6015844 | Harvey et al. | Jan 2000 | A |
6039686 | Robert | Mar 2000 | A |
6042534 | Gellman et al. | Mar 2000 | A |
6042592 | Schmitt | Mar 2000 | A |
6043089 | Sugiyama et al. | Mar 2000 | A |
6051425 | Morota et al. | Apr 2000 | A |
6056688 | Benderev et al. | May 2000 | A |
6056970 | Greenawalt et al. | May 2000 | A |
6057148 | Sugiyama et al. | May 2000 | A |
6063396 | Kelleher | May 2000 | A |
6066776 | Goodwin et al. | May 2000 | A |
6066777 | Benchetrit | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6077281 | Das | Jun 2000 | A |
6080194 | Pachence et al. | Jun 2000 | A |
6083522 | Chu et al. | Jul 2000 | A |
6090116 | D Aversa et al. | Jul 2000 | A |
6113623 | Sgro | Sep 2000 | A |
6120539 | Eldridge et al. | Sep 2000 | A |
6132765 | Dicosmo et al. | Oct 2000 | A |
6143037 | Goldstein et al. | Nov 2000 | A |
6153292 | Bell et al. | Nov 2000 | A |
6162962 | Hinsch et al. | Dec 2000 | A |
6165488 | Tardy et al. | Dec 2000 | A |
6171318 | Kugel et al. | Jan 2001 | B1 |
6174320 | Kugel et al. | Jan 2001 | B1 |
6176863 | Kugel et al. | Jan 2001 | B1 |
6179872 | Bell et al. | Jan 2001 | B1 |
6180848 | Flament et al. | Jan 2001 | B1 |
6191334 | Patterson | Feb 2001 | B1 |
6197325 | Macphee et al. | Mar 2001 | B1 |
6197934 | Devore et al. | Mar 2001 | B1 |
6197935 | Doillon et al. | Mar 2001 | B1 |
6210439 | Firmin et al. | Apr 2001 | B1 |
6214020 | Mulhauser et al. | Apr 2001 | B1 |
6221109 | Geistlich et al. | Apr 2001 | B1 |
6224616 | Kugel | May 2001 | B1 |
6241768 | Agarwal et al. | Jun 2001 | B1 |
6258124 | Darois et al. | Jul 2001 | B1 |
6262332 | Ketharanathan | Jul 2001 | B1 |
6264702 | Ory et al. | Jul 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6270530 | Eldridge et al. | Aug 2001 | B1 |
6277397 | Shimizu | Aug 2001 | B1 |
6280453 | Kugel et al. | Aug 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6290708 | Kugel et al. | Sep 2001 | B1 |
6306079 | Trabucco | Oct 2001 | B1 |
6306424 | Vyakarnam et al. | Oct 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6319264 | Tormala et al. | Nov 2001 | B1 |
6328686 | Robert | Dec 2001 | B1 |
6334872 | Termin et al. | Jan 2002 | B1 |
6337389 | Wolfinbarger, Jr. | Jan 2002 | B1 |
6383201 | Dong | May 2002 | B1 |
6391060 | Ory et al. | May 2002 | B1 |
6391333 | Li et al. | May 2002 | B1 |
6391939 | Tayot et al. | May 2002 | B2 |
6408656 | Ory et al. | Jun 2002 | B1 |
6410044 | Chudzik et al. | Jun 2002 | B1 |
6413742 | Olsen et al. | Jul 2002 | B1 |
6425924 | Rousseau | Jul 2002 | B1 |
6428978 | Olsen et al. | Aug 2002 | B1 |
6436030 | Rehil | Aug 2002 | B2 |
6440167 | Shimizu | Aug 2002 | B2 |
6443964 | Ory et al. | Sep 2002 | B1 |
6447551 | Goldmann | Sep 2002 | B1 |
6447802 | Sessions et al. | Sep 2002 | B2 |
6448378 | Devore et al. | Sep 2002 | B2 |
6451032 | Ory et al. | Sep 2002 | B1 |
6451301 | Sessions et al. | Sep 2002 | B1 |
6454787 | Maddalo et al. | Sep 2002 | B1 |
6477865 | Matsumoto | Nov 2002 | B1 |
6479072 | Morgan et al. | Nov 2002 | B1 |
6485503 | Jacobs et al. | Nov 2002 | B2 |
6500464 | Ceres et al. | Dec 2002 | B2 |
6500777 | Wiseman et al. | Dec 2002 | B1 |
6509031 | Miller et al. | Jan 2003 | B1 |
6511958 | Atkinson et al. | Jan 2003 | B1 |
6514286 | Leatherbury et al. | Feb 2003 | B1 |
6514514 | Atkinson et al. | Feb 2003 | B1 |
6540773 | Dong | Apr 2003 | B2 |
6541023 | Andre et al. | Apr 2003 | B1 |
6548077 | Gunasekaran | Apr 2003 | B1 |
6554855 | Dong | Apr 2003 | B1 |
6559119 | Burgess et al. | May 2003 | B1 |
6566345 | Miller et al. | May 2003 | B2 |
6575988 | Rousseau | Jun 2003 | B2 |
6576019 | Atala | Jun 2003 | B1 |
6596002 | Therin et al. | Jul 2003 | B2 |
6596304 | Bayon | Jul 2003 | B1 |
6599323 | Melican et al. | Jul 2003 | B2 |
6599524 | Li et al. | Jul 2003 | B2 |
6599690 | Abraham et al. | Jul 2003 | B1 |
6610006 | Amid et al. | Aug 2003 | B1 |
6613348 | Jain | Sep 2003 | B1 |
6616685 | Rousseau | Sep 2003 | B2 |
6623963 | Mueller et al. | Sep 2003 | B1 |
6627215 | Dale et al. | Sep 2003 | B1 |
6630414 | Matsumoto | Oct 2003 | B1 |
6637437 | Hungerford et al. | Oct 2003 | B1 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6645226 | Jacobs et al. | Nov 2003 | B1 |
6652594 | Francis et al. | Nov 2003 | B2 |
6652595 | Nicolo | Nov 2003 | B1 |
6653450 | Berg et al. | Nov 2003 | B1 |
6656206 | Corcoran et al. | Dec 2003 | B2 |
6660280 | Allard et al. | Dec 2003 | B1 |
6669735 | Pelissier | Dec 2003 | B1 |
6670018 | Fujita et al. | Dec 2003 | B2 |
6682760 | Noff et al. | Jan 2004 | B2 |
6685714 | Rousseau | Feb 2004 | B2 |
6706684 | Bayon et al. | Mar 2004 | B1 |
6706690 | Reich et al. | Mar 2004 | B2 |
6712859 | Rousseau et al. | Mar 2004 | B2 |
6719795 | Bryan et al. | Apr 2004 | B1 |
6723335 | Moehlenbruck et al. | Apr 2004 | B1 |
6726660 | Hessel et al. | Apr 2004 | B2 |
6730299 | Tayot et al. | May 2004 | B1 |
6736823 | Darois et al. | May 2004 | B2 |
6736854 | Vadurro et al. | May 2004 | B2 |
6737371 | Planck et al. | May 2004 | B1 |
6743435 | Devore et al. | Jun 2004 | B2 |
6746458 | Cloud | Jun 2004 | B1 |
6752834 | Geistlich et al. | Jun 2004 | B2 |
6755868 | Rousseau | Jun 2004 | B2 |
6773723 | Spiro et al. | Aug 2004 | B1 |
6783554 | Amara et al. | Aug 2004 | B2 |
6790213 | Cherok et al. | Sep 2004 | B2 |
6790454 | Abdul et al. | Sep 2004 | B1 |
6800082 | Rousseau | Oct 2004 | B2 |
6833408 | Sehl et al. | Dec 2004 | B2 |
6835336 | Watt | Dec 2004 | B2 |
6852330 | Bowman et al. | Feb 2005 | B2 |
6869938 | Schwartz et al. | Mar 2005 | B1 |
6872227 | Sump et al. | Mar 2005 | B2 |
6893653 | Abraham et al. | May 2005 | B2 |
6896904 | Spiro et al. | May 2005 | B2 |
6926723 | Mulhauser et al. | Aug 2005 | B1 |
6936276 | Spiro et al. | Aug 2005 | B2 |
6939562 | Spiro et al. | Sep 2005 | B2 |
6949625 | Tayot | Sep 2005 | B2 |
6966918 | Schuldt-Hempe et al. | Nov 2005 | B1 |
6971252 | Therin et al. | Dec 2005 | B2 |
6974679 | Andre et al. | Dec 2005 | B2 |
6974862 | Ringeisen et al. | Dec 2005 | B2 |
6977231 | Matsuda | Dec 2005 | B1 |
6984392 | Bechert et al. | Jan 2006 | B2 |
6988386 | Okawa et al. | Jan 2006 | B1 |
7011688 | Gryska et al. | Mar 2006 | B2 |
7021086 | Ory et al. | Apr 2006 | B2 |
7022358 | Eckmayer et al. | Apr 2006 | B2 |
7025063 | Snitkin et al. | Apr 2006 | B2 |
7041868 | Greene et al. | May 2006 | B2 |
7060103 | Carr et al. | Jun 2006 | B2 |
RE39172 | Bayon et al. | Jul 2006 | E |
7070558 | Gellman et al. | Jul 2006 | B2 |
7087065 | Ulmsten et al. | Aug 2006 | B2 |
7094261 | Zotti et al. | Aug 2006 | B2 |
7098315 | Schaufler | Aug 2006 | B2 |
7101381 | Ford et al. | Sep 2006 | B2 |
7115220 | Dubson et al. | Oct 2006 | B2 |
7156804 | Nicolo | Jan 2007 | B2 |
7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
7175852 | Simmoteit et al. | Feb 2007 | B2 |
7192604 | Brown et al. | Mar 2007 | B2 |
7207962 | Anand et al. | Apr 2007 | B2 |
7214765 | Ringeisen et al. | May 2007 | B2 |
7226611 | Yura et al. | Jun 2007 | B2 |
7229453 | Anderson et al. | Jun 2007 | B2 |
7252837 | Guo et al. | Aug 2007 | B2 |
7279177 | Looney et al. | Oct 2007 | B2 |
7331199 | Ory et al. | Feb 2008 | B2 |
7393319 | Merade et al. | Jul 2008 | B2 |
7556598 | Rao | Jul 2009 | B2 |
7594921 | Browning | Sep 2009 | B2 |
7614258 | Cherok et al. | Nov 2009 | B2 |
7615065 | Priewe et al. | Nov 2009 | B2 |
7662169 | Wittmann | Feb 2010 | B2 |
7670380 | Cauthen, III et al. | Mar 2010 | B2 |
7682381 | Rakos et al. | Mar 2010 | B2 |
7709017 | Tayot et al. | May 2010 | B2 |
7718556 | Matsuda et al. | May 2010 | B2 |
7732354 | Fricke et al. | Jun 2010 | B2 |
7785334 | Ford et al. | Aug 2010 | B2 |
7789888 | Bartee et al. | Sep 2010 | B2 |
7799767 | Lamberti et al. | Sep 2010 | B2 |
7806905 | Ford et al. | Oct 2010 | B2 |
7824420 | Eldridge et al. | Nov 2010 | B2 |
7828854 | Rousseau et al. | Nov 2010 | B2 |
7900484 | Cherok et al. | Mar 2011 | B2 |
7931695 | Ringeisen | Apr 2011 | B2 |
8052759 | Dupic et al. | Nov 2011 | B2 |
8079023 | Chen | Dec 2011 | B2 |
8100924 | Browning | Jan 2012 | B2 |
8123817 | Intoccia et al. | Feb 2012 | B2 |
8142515 | Therin et al. | Mar 2012 | B2 |
8157821 | Browning | Apr 2012 | B2 |
8157822 | Browning | Apr 2012 | B2 |
8182545 | Cherok et al. | May 2012 | B2 |
8197837 | Jamiolkowski et al. | Jun 2012 | B2 |
8206632 | Rousseau et al. | Jun 2012 | B2 |
8215310 | Browning | Jul 2012 | B2 |
8317872 | Adams | Nov 2012 | B2 |
8323675 | Greenawalt | Dec 2012 | B2 |
8343232 | Adzich et al. | Jan 2013 | B2 |
8366787 | Brown et al. | Feb 2013 | B2 |
8435307 | Paul | May 2013 | B2 |
8470355 | Skalla et al. | Jun 2013 | B2 |
8562633 | Cully et al. | Oct 2013 | B2 |
8574627 | Martakos et al. | Nov 2013 | B2 |
8709094 | Stad et al. | Apr 2014 | B2 |
8734471 | Deitch | May 2014 | B2 |
8753360 | Gleiman et al. | Jun 2014 | B2 |
8758800 | Stopek et al. | Jun 2014 | B2 |
8784294 | Goddard | Jul 2014 | B2 |
8814887 | Walther et al. | Aug 2014 | B2 |
8828092 | Toso et al. | Sep 2014 | B2 |
8834864 | Odar et al. | Sep 2014 | B2 |
8846060 | Archibald et al. | Sep 2014 | B2 |
8865215 | Ladet et al. | Oct 2014 | B2 |
8877233 | Obermiller et al. | Nov 2014 | B2 |
8911504 | Mathisen et al. | Dec 2014 | B2 |
8920370 | Sholev et al. | Dec 2014 | B2 |
8956373 | Ford et al. | Feb 2015 | B2 |
8962006 | Bayon et al. | Feb 2015 | B2 |
8968762 | Ladet et al. | Mar 2015 | B2 |
8979935 | Lozier et al. | Mar 2015 | B2 |
9034357 | Stopek | May 2015 | B2 |
9113993 | Lee | Aug 2015 | B2 |
9211175 | Stopek et al. | Dec 2015 | B2 |
9216075 | Bailly et al. | Dec 2015 | B2 |
20010008930 | Tayot | Jul 2001 | A1 |
20020087174 | Capello | Jul 2002 | A1 |
20020095218 | Carr et al. | Jul 2002 | A1 |
20020132240 | Ashkenazi | Sep 2002 | A1 |
20030086975 | Ringeisen | May 2003 | A1 |
20030114937 | Leatherbury et al. | Jun 2003 | A1 |
20030133967 | Ruszczak et al. | Jul 2003 | A1 |
20030225355 | Butler | Dec 2003 | A1 |
20040034373 | Schuldt-Hempe et al. | Feb 2004 | A1 |
20040054376 | Ory et al. | Mar 2004 | A1 |
20040059356 | Gingras | Mar 2004 | A1 |
20040062910 | Morrison | Apr 2004 | A1 |
20040101546 | Gorman et al. | May 2004 | A1 |
20050002893 | Goldmann | Jan 2005 | A1 |
20050021058 | Negro | Jan 2005 | A1 |
20050085924 | Darois et al. | Apr 2005 | A1 |
20050113849 | Popadiuk et al. | May 2005 | A1 |
20050137512 | Campbell et al. | Jun 2005 | A1 |
20050142161 | Freeman et al. | Jun 2005 | A1 |
20050148963 | Brennan | Jul 2005 | A1 |
20050175659 | Macomber et al. | Aug 2005 | A1 |
20050232979 | Shoshan | Oct 2005 | A1 |
20050267521 | Forsberg | Dec 2005 | A1 |
20050288691 | Leiboff | Dec 2005 | A1 |
20060116696 | Odermatt et al. | Jun 2006 | A1 |
20060135921 | Wiercinski et al. | Jun 2006 | A1 |
20060147501 | Hillas et al. | Jul 2006 | A1 |
20060216320 | Kitazono et al. | Sep 2006 | A1 |
20060252981 | Matsuda et al. | Nov 2006 | A1 |
20060253203 | Alvarado | Nov 2006 | A1 |
20060282103 | Fricke et al. | Dec 2006 | A1 |
20070088391 | Mcalexander et al. | Apr 2007 | A1 |
20070129736 | Solecki | Jun 2007 | A1 |
20070198040 | Buevich et al. | Aug 2007 | A1 |
20070299538 | Roeber | Dec 2007 | A1 |
20080091276 | Deusch et al. | Apr 2008 | A1 |
20080109017 | Herweck et al. | May 2008 | A1 |
20080113001 | Herweck et al. | May 2008 | A1 |
20080172071 | Barker | Jul 2008 | A1 |
20080243149 | Kockerling | Oct 2008 | A1 |
20080255593 | St-Germain | Oct 2008 | A1 |
20090005867 | Lefranc et al. | Jan 2009 | A1 |
20090035341 | Wagener et al. | Feb 2009 | A1 |
20090036996 | Roeber | Feb 2009 | A1 |
20090036997 | Bayon | Feb 2009 | A1 |
20090068250 | Gravagna et al. | Mar 2009 | A1 |
20090105526 | Piroli et al. | Apr 2009 | A1 |
20090163936 | Yang et al. | Jun 2009 | A1 |
20090187197 | Roeber et al. | Jul 2009 | A1 |
20090192530 | Adzich et al. | Jul 2009 | A1 |
20090192532 | Spinnler | Jul 2009 | A1 |
20090204129 | Fronio | Aug 2009 | A1 |
20090216338 | Gingras et al. | Aug 2009 | A1 |
20090240288 | Guetty | Sep 2009 | A1 |
20090270999 | Brown | Oct 2009 | A1 |
20090281558 | Li et al. | Nov 2009 | A1 |
20090318752 | Evans | Dec 2009 | A1 |
20100104608 | Abuzaina et al. | Apr 2010 | A1 |
20100318108 | Datta et al. | Dec 2010 | A1 |
20110015760 | Kullas | Jan 2011 | A1 |
20110144667 | Horton et al. | Jun 2011 | A1 |
20110190795 | Hotter et al. | Aug 2011 | A1 |
20110238094 | Thomas et al. | Sep 2011 | A1 |
20110251699 | Ladet et al. | Oct 2011 | A1 |
20110257666 | Ladet | Oct 2011 | A1 |
20110320009 | Ladet | Dec 2011 | A1 |
20120010636 | Boey | Jan 2012 | A1 |
20120010637 | Stopek | Jan 2012 | A1 |
20120016388 | Houard et al. | Jan 2012 | A1 |
20120029537 | Mortarino | Feb 2012 | A1 |
20120065727 | Reneker et al. | Mar 2012 | A1 |
20120082712 | Stopek et al. | Apr 2012 | A1 |
20120116425 | Intoccia et al. | May 2012 | A1 |
20120150204 | Mortarino et al. | Jun 2012 | A1 |
20120165937 | Montanari et al. | Jun 2012 | A1 |
20120179175 | Hammell et al. | Jul 2012 | A1 |
20120179176 | Wilson et al. | Jul 2012 | A1 |
20120197415 | Montanari et al. | Aug 2012 | A1 |
20130078285 | Ladet | Mar 2013 | A1 |
20140044861 | Boey et al. | Feb 2014 | A1 |
20140364684 | Lecuivre et al. | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
1317836 | May 1993 | CA |
201879864 | Jun 2011 | CN |
19544162 | Apr 1997 | DE |
19718903 | Dec 1997 | DE |
19751733 | Dec 1998 | DE |
19832634 | Jan 2000 | DE |
10019604 | Oct 2001 | DE |
10120942 | Oct 2001 | DE |
10043396 | Jun 2002 | DE |
0194192 | Sep 1986 | EP |
0248544 | Dec 1987 | EP |
0263360 | Apr 1988 | EP |
0276890 | Aug 1988 | EP |
0372969 | Jun 1990 | EP |
0531742 | Mar 1993 | EP |
0544485 | Jun 1993 | EP |
0552576 | Jul 1993 | EP |
0611561 | Aug 1994 | EP |
0614650 | Sep 1994 | EP |
0621014 | Oct 1994 | EP |
0625891 | Nov 1994 | EP |
0637452 | Feb 1995 | EP |
0664132 | Jul 1995 | EP |
0705878 | Apr 1996 | EP |
0719527 | Jul 1996 | EP |
0774240 | May 1997 | EP |
0797962 | Oct 1997 | EP |
0800791 | Oct 1997 | EP |
0827724 | Mar 1998 | EP |
0836838 | Apr 1998 | EP |
0847727 | Jun 1998 | EP |
0876808 | Nov 1998 | EP |
0895762 | Feb 1999 | EP |
0898944 | Mar 1999 | EP |
1017415 | Jul 2000 | EP |
1036545 | Sep 2000 | EP |
1052319 | Nov 2000 | EP |
1055757 | Nov 2000 | EP |
1090590 | Apr 2001 | EP |
1216717 | Jun 2002 | EP |
1216718 | Jun 2002 | EP |
0693523 | Nov 2002 | EP |
1273312 | Jan 2003 | EP |
1315468 | Jun 2003 | EP |
1382728 | Jan 2004 | EP |
1484070 | Dec 2004 | EP |
1561480 | Aug 2005 | EP |
1645232 | Apr 2006 | EP |
1674048 | Jun 2006 | EP |
1691606 | Aug 2006 | EP |
1782848 | May 2007 | EP |
2229918 | Sep 2010 | EP |
2244853 | Apr 1975 | FR |
2257262 | Aug 1975 | FR |
2308349 | Nov 1976 | FR |
2453231 | Oct 1980 | FR |
2612392 | Sep 1988 | FR |
2715309 | Jul 1995 | FR |
2715405 | Jul 1995 | FR |
2724563 | Mar 1996 | FR |
2730406 | Aug 1996 | FR |
2744906 | Aug 1997 | FR |
2766698 | Feb 1999 | FR |
2771622 | Jun 1999 | FR |
2773057 | Jul 1999 | FR |
2774277 | Aug 1999 | FR |
2779937 | Dec 1999 | FR |
2846548 | May 2004 | FR |
2859624 | Mar 2005 | FR |
2863277 | Jun 2005 | FR |
2876020 | Apr 2006 | FR |
2884706 | Oct 2006 | FR |
2929834 | Oct 2009 | FR |
2953709 | Jun 2011 | FR |
1174814 | Dec 1969 | GB |
2051153 | Jan 1981 | GB |
2306110 | Apr 1997 | GB |
H0332677 | Feb 1991 | JP |
H05237128 | Sep 1993 | JP |
H09137380 | May 1997 | JP |
H11146888 | Jun 1999 | JP |
2008538300 | Oct 2008 | JP |
2011078767 | Apr 2011 | JP |
8902445 | Mar 1989 | WO |
8908467 | Sep 1989 | WO |
9012551 | Nov 1990 | WO |
9206639 | Apr 1992 | WO |
9220349 | Nov 1992 | WO |
9310731 | Jun 1993 | WO |
9311805 | Jun 1993 | WO |
9318174 | Sep 1993 | WO |
9417747 | Aug 1994 | WO |
9507666 | Mar 1995 | WO |
9518638 | Jul 1995 | WO |
9532687 | Dec 1995 | WO |
9603091 | Feb 1996 | WO |
9608277 | Mar 1996 | WO |
9609795 | Apr 1996 | WO |
9614805 | May 1996 | WO |
9641588 | Dec 1996 | WO |
9735533 | Oct 1997 | WO |
9835632 | Aug 1998 | WO |
9849967 | Nov 1998 | WO |
9905990 | Feb 1999 | WO |
9906079 | Feb 1999 | WO |
9906080 | Feb 1999 | WO |
9951163 | Oct 1999 | WO |
0016821 | Mar 2000 | WO |
0067663 | Nov 2000 | WO |
0115625 | Mar 2001 | WO |
0180773 | Nov 2001 | WO |
0181667 | Nov 2001 | WO |
0207648 | Jan 2002 | WO |
0217853 | Mar 2002 | WO |
02078568 | Oct 2002 | WO |
03002168 | Jan 2003 | WO |
2004004600 | Jan 2004 | WO |
2004071349 | Aug 2004 | WO |
2004078120 | Sep 2004 | WO |
2004103212 | Dec 2004 | WO |
2005011280 | Feb 2005 | WO |
2005013863 | Feb 2005 | WO |
2005018698 | Mar 2005 | WO |
2005048708 | Jun 2005 | WO |
2005105172 | Nov 2005 | WO |
2006018552 | Feb 2006 | WO |
2006023444 | Mar 2006 | WO |
2007048099 | Apr 2007 | WO |
2009031035 | Mar 2009 | WO |
2009071998 | Jun 2009 | WO |
2010043978 | Apr 2010 | WO |
2011007062 | Jan 2011 | WO |
2011026987 | Mar 2011 | WO |
WO-2011026987 | Mar 2011 | WO |
2011038740 | Apr 2011 | WO |
2011042811 | Apr 2011 | WO |
Entry |
---|
Canadian Office Action issued in corresponding Canadian application No. 2,858,003 dated May 3, 2019, 3 pages. |
Amid, R., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003. |
Australian Examination Report dated Dec. 16, 2016 in corresponding Australian Patent Application No. 2012360857, 3 pages. |
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4). |
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6). |
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1). |
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004. |
Canadian Office Action issued in corresponding Canadian application No. 2,858,003 dated Oct. 12, 2018, 3 pages. |
Dhastan, “Tension Free Open Inguinal Hernia Repair Using an Innovative Self Gripping Semi-Resorbable Mesh,” J. Min. Access. Surg., Sep. 2006, pp. 139-143, vol. 2. |
Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506. |
Chinese Office Action dated Apr. 5, 2016 in corresponding Chinese Patent Application No. 201280065573.1, together with English language translation, 23 pages. |
Chinese Office Action dated Oct. 21, 2016 in corresponding Chinese Patent Application No. 201280065573.1 together with English translation, 22 pages. |
Chinese Office Action, Application No. 2012800655731 dated Jul. 28, 2015 and English translation. |
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical aterials Research, Feb. 1991, pp. 267-276, vol. 25. |
Covidien, “Parietex ProGrip Self-Fixating Mesh,” Hernia Repair Products, retrieved Dec. 7, 2012, http://www.covidien.com/campaigns/pagebuilder.aspx?topiciD=172431 &page=Hernia:Parietex>, pp. 1-2. |
Covidien, “Procedures Parietex ProGrip Self-Fixating Mesh,” Hernia Solutions, retrieved Dec. 7, 2012, (select United States), pp. 1-2. |
Dixit et al., “Oral Strip Technology: Overview and Future Potential,” Journal of Controlled Release, Jun. 2009, pp. 34-107, vol. 139. |
Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany. |
Ellouali, M. et al., “Antitumor Activity of Low Molecular Weight Fucans Extracted from Brown Seaweed Ascophyllum nodosum,” Anticancer Res , Nov.-Dec. 1993, pp. 2011-2020, 12 (6A). |
European Office Action dated Dec. 19, 2017 in corresponding European Patent Application No. 12812670.3, 3 pages. |
Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009. |
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4). |
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5). |
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19. |
International Search Report for PCT/EP12/076983 date of completion is Mar. 11, 2013 (3 pages). |
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26. |
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3). |
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165. |
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63. |
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7). |
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). |
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36. |
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10. |
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2). |
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136. |
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34. |
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007. |
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220, 18(2). |
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2. |
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299. |
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5. |
Zyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215, 126(3). |
Communication pursuant to Article 94(3) EPC issued in European Application No. 12812670.3 dated Jul. 28, 2020, 5 pages. |
Number | Date | Country | |
---|---|---|---|
20190008625 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14366332 | US | |
Child | 16128549 | US |